RxDoctor Payments Data

John Chatas, MD

Interventional Pain Medicine · Ann Arbor, MINPI 1083710107

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (38.2%), food and beverage and education — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Boston Scientific at 47.2% of the total. Reporting peaked in 2021 at $10,782 and has fallen 89.8% since, to $1,103 in 2025. Among interventional pain medicine clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$28,776in general payments, 2019–2025

Across 260 payments — averaging $110.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$14K
  • Painteq LLC$7K
  • Saluda Medical Americas, Inc.$3K
  • Vertiflex, Inc.$1K
  • Abbott$1K
  • Nevro Corp.$708
  • plus $3K from 21 others
$60,629in research payments, 2019–2025

Across 27 payments — averaging $2245.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$61K

What the payments were for

  • Speaking & faculty fees$11,00038%
  • Travel & lodging$4,06514%
  • Food & beverage$7,18025%
  • Education$6,53023%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$28,776 in reported general payments places this provider in the 90th percentile of 88 interventional pain medicine providers in Michigan.

See all interventional pain medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$245,361
Medicare patients
201
Services billed
29,427

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen38$375
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen18$194
Oxycodone Hcl11$158
Cefadroxil15$66
Prednisone16$34
Tramadol Hcl11$22

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →